FindTrial
Sign In

Clinical profile of neonates born to mothers with COVID-19

A study on the clinical profile of neonates born to mothers with COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027175
Enrollment
50
Registered
2020-08-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Government
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All neonates born to mothers with COVID-19

Exclusion criteria

Exclusion criteria: neonates born to mothers taking teratogenic drugs, exposure to teratogenic dose of radiation, infections like varicella and TORCH and addictions like smoking and alcoholism

Design outcomes

Primary

MeasureTime frame
Clinical outcome,Congenital anomaliesTimepoint: Immediate, Follow up for 28 days of life—

Secondary

MeasureTime frame
NICU admission and invasive managementTimepoint: Immediate and follow up for 28 days of life—

Countries

India

Contacts

Public ContactAmbili Susan Jacob

Government Medical College,Kannur

ambilisusanjacob@gmail.com9447664165

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026